LCTX Lineage Cell Therapeutics, Inc.
Fundamentals / CIK 0000876343 / USDLineage Cell Therapeutics, Inc. reported $10.84M in revenue and net income of $1.75M for the trailing twelve months ended September 30, 2026 (down 61.0% year over year), with a -280.3% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LCTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$10.84M -61.0% YoY
-
Operating Income TTM-$30.38M -280.3% margin
-
Net Income TTM$1.75M 16.2% net margin
-
Diluted EPS TTM$0.01 Split-adjusted
-
Free Cash Flow TTM-$26.46M -244.1% FCF margin
-
Cash & ST Investments Sep 30, 2026$45.18M Total debt: $2.03M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.56M | $9.50M | $8.95M | $14.70M | $4.34M | $1.83M | $3.52M | $4.99M | $3.46M | $5.92M |
| Cost of Revenue | -- | $334K | $671K | $728K | $1.43M | $385K | $412K | $302K | $168K | $358K |
| Gross Profit | -- | $9.16M | $8.27M | $13.97M | $2.92M | $1.44M | $3.10M | $4.69M | $3.29M | $5.57M |
| Research & Development | $17.73M | $12.47M | $15.71M | $13.99M | $33.91M | $12.32M | $17.95M | $20.95M | $24.02M | $36.11M |
| Total Operating Expenses | -- | -- | $33.01M | $36.49M | $52.13M | $27.89M | $41.98M | $46.48M | $43.95M | $64.53M |
| Operating Income | -$36.62M | -$21.48M | -$24.73M | -$22.52M | -$49.21M | -$26.45M | -$38.88M | -$41.80M | -$38.90M | -$58.97M |
| EBITDA | -$35.92M | -$20.89M | -$24.17M | -$21.94M | -$48.55M | -$25.62M | -$37.87M | -$40.71M | -$37.95M | -$57.79M |
| Interest Income | -- | -- | -- | -- | -- | $1.04M | $1.69M | -- | -- | -- |
| Income Before Tax | -$68.65M | -$18.58M | -$23.28M | -$25.81M | -$43.27M | -$21.92M | -$19.23M | -$47.13M | -$23.29M | $18.62M |
| Income Tax Expense | -$5.28M | $0 | -$1.80M | $541K | -- | -$1.24M | -$7.41M | $346K | -- | -- |
| Net Income | -$63.53M | -$18.61M | -$21.49M | -$26.27M | -$43.02M | -$20.65M | -$11.71M | -$45.99M | -$19.98M | $33.57M |
| Basic EPS | -$0.28 | -$0.09 | -$0.12 | -$0.15 | -$0.26 | -$0.14 | -$0.08 | -$0.36 | -$0.17 | $0.35 |
| Diluted EPS | -$0.28 | -$0.09 | -$0.12 | -$0.15 | -$0.26 | -$0.14 | -$0.08 | -$0.36 | -$0.17 | $0.34 |
| Basic Shares Outstanding | 230.1M | 200.2M | 172.7M | 169.8M | 164.5M | 150.0K | 145.5K | 126.9K | 114.5M | 97.3M |
| Diluted Shares Outstanding | 230.1M | 200.2M | 172.7M | 169.8M | 164.5K | 150.0K | 145.5K | 126.9K | 114.5M | 99.6M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.43M | $1.07M | $1.73M | $6.61M | $3.68M | $2.77M | $1.50M | $2.87M |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | $36K | $154K |
| Gross Profit | -- | -- | -- | -- | -- | -- | $1.47M | $2.71M |
| Research & Development | $3.82M | $4.77M | $4.23M | $8.24M | $3.27M | $3.11M | $3.11M | $3.42M |
| Operating Income | -$7.31M | -$8.92M | -$7.59M | -$6.55M | -$3.79M | -$19.78M | -$6.50M | -$5.11M |
| EBITDA | -$7.11M | -$8.74M | -$7.41M | -$6.36M | -$3.61M | -$19.61M | -$6.34M | -$4.96M |
| Income Before Tax | $4.71M | -- | -- | -- | -$29.75M | -- | -- | -$3.25M |
| Income Tax Expense | $484K | -- | -- | -- | $0 | -- | -- | $0 |
| Net Income | $4.23M | $1.48M | -$4.81M | $851K | -$29.78M | -$30.46M | -$4.14M | -$3.27M |
| Basic EPS | $0.02 | $0.01 | -$0.02 | -- | -$0.13 | -$0.13 | -$0.02 | -- |
| Diluted EPS | -$0.03 | -$0.03 | -$0.03 | -- | -$0.13 | -$0.13 | -$0.02 | -- |
| Basic Shares Outstanding | 252.9M | 249.5M | 245.0M | -- | 228.9M | 228.4M | 226.1M | -- |
| Diluted Shares Outstanding | 259.1M | 261.5M | 261.2M | -- | 228.9M | 228.4M | 226.1M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $40.79M | $45.79M | $35.44M | $11.36M | $55.74M | $32.59M | $9.50M | $23.59M | $36.84M | $22.09M |
| Short-Term Investments | $14.99M | $2.02M | $50K | $46.52M | $2.62M | $8.98M | $21.22M | $7.15M | $1.34M | -- |
| Cash & Short-Term Investments | $55.78M | $47.80M | $35.49M | $57.88M | $58.40M | $41.60M | $30.70M | $30.70M | $38.20M | $12.50M |
| Accounts Receivable, Net | $891K | $638K | $745K | $297K | $50.60M | $242K | $44K | $51K | $139K | $344K |
| Total Current Assets | $59.16M | $51.00M | $38.44M | $60.00M | $111.5M | $44.00M | $57.52M | $36.36M | $42.62M | $25.65M |
| Property, Plant & Equipment, Net | $2.57M | $2.25M | $2.25M | $5.67M | $4.87M | $5.63M | $8.18M | $5.83M | $5.53M | $5.53M |
| Goodwill | $10.67M | $10.67M | $10.67M | $10.67M | $10.67M | $10.67M | $10.67M | -- | -- | -- |
| Intangible Assets | $31.70M | $46.54M | $46.56M | $46.69M | $46.82M | $47.03M | $48.25M | $3.12M | $6.90M | $10.21M |
| Total Non-Current Assets | $53.43M | $62.22M | $62.58M | $63.66M | $63.00M | $63.95M | $67.96M | $65.30M | $130.6M | $116.9M |
| Total Assets | $112.6M | $113.2M | $101.0M | $123.7M | $174.5M | $107.9M | $125.5M | $101.7M | $173.2M | $142.6M |
| Accounts Payable | $2.34M | $1.17M | $2.05M | $2.39M | $3.54M | $2.61M | $2.43M | $2.36M | $938K | $1.59M |
| Deferred Revenue (Current) | $3.33M | $7.39M | $10.80M | $9.40M | $52.10M | $193K | $45K | $42K | $309K | $572K |
| Total Current Liabilities | $11.37M | $13.98M | $17.96M | $18.98M | $47.12M | $7.77M | $6.49M | $6.81M | $6.88M | $8.85M |
| Deferred Revenue (Non-Current) | $12.38M | $14.43M | $18.69M | $27.73M | $32.45M | -- | $200K | $3.50M | -- | $308K |
| Other Non-Current Liabilities | -- | -- | $0 | $2.0K | $30K | -- | -- | -- | -- | $8.0K |
| Total Non-Current Liabilities | $57.87M | $22.23M | $21.04M | $32.75M | $36.53M | $5.05M | $7.74M | $2.60M | $2.10M | $3.21M |
| Total Liabilities | $69.24M | $36.21M | $39.00M | $51.73M | $83.65M | $12.82M | $14.23M | $9.41M | $8.98M | $12.06M |
| Total Debt (incl. Leases) | $2.42M | $2.51M | $2.95M | $3.90M | $2.80M | $284K | $942K | $2.19M | -- | -- |
| Common Stock | $515.5M | $484.7M | $451.3M | $440.3M | $434.5M | $393.9M | $387.1M | $354.3M | $378.5M | $317.9M |
| Retained Earnings | -$467.0M | -$403.5M | -$384.9M | -$363.4M | -$337.1M | -$294.1M | -$273.4M | -$261.9M | -$216.3M | -$196.3M |
| Accumulated Other Comp. Income | -$3.92M | -$2.88M | -$3.07M | -$3.57M | -$5.21M | -$3.67M | -$681K | $1.43M | $451K | -$738K |
| Total Stockholders' Equity | $44.55M | $78.38M | $63.42M | $73.34M | $92.22M | $96.20M | $113.0M | $92.25M | $162.6M | $117.9M |
| Total Equity | $43.35M | $77.01M | $62.02M | $71.94M | $90.90M | $95.13M | $111.2M | $92.25M | $164.3M | $130.5M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $26.50M | $37.35M | $35.94M | $40.79M | $40.46M | $42.27M | $47.89M | $45.79M |
| Short-Term Investments | $18.68M | $13.47M | $17.44M | $14.99M | $23K | $17K | $19K | $2.02M |
| Cash & Short-Term Investments | $45.18M | $50.83M | $53.38M | $55.78M | $40.49M | $42.29M | $47.91M | $47.80M |
| Accounts Receivable, Net | $1.33M | $790K | $806K | $891K | $127K | $256K | $213K | $638K |
| Total Current Assets | $47.77M | $52.97M | $56.16M | $59.16M | $42.26M | $43.84M | $49.98M | $51.00M |
| Property, Plant & Equipment, Net | $2.38M | $2.52M | $2.50M | $2.57M | $2.16M | $2.25M | $2.15M | $2.25M |
| Goodwill | $10.67M | $10.67M | $10.67M | $10.67M | $10.67M | $10.67M | $10.67M | $10.67M |
| Intangible Assets | $31.70M | $31.70M | $31.70M | $31.70M | $31.70M | $31.70M | $46.54M | $46.54M |
| Total Non-Current Assets | $52.34M | $53.25M | $53.37M | $53.43M | $47.38M | $46.95M | $61.77M | $62.22M |
| Total Assets | $100.1M | $106.2M | $109.5M | $112.6M | $89.64M | $90.80M | $111.8M | $113.2M |
| Accounts Payable | $1.64M | $1.54M | $1.59M | $2.34M | $1.52M | $1.50M | $2.00M | $1.17M |
| Deferred Revenue (Current) | $1.42M | $1.68M | $1.72M | $3.33M | $3.77M | $5.26M | $6.93M | $7.39M |
| Total Current Liabilities | $8.02M | $8.02M | $8.15M | $11.37M | $9.38M | $10.76M | $13.09M | $13.98M |
| Deferred Revenue (Non-Current) | $12.34M | $12.34M | $13.00M | $12.38M | $12.46M | $12.75M | $13.61M | $14.43M |
| Total Non-Current Liabilities | $26.15M | $38.41M | $48.69M | $57.87M | $59.46M | $32.93M | $21.01M | $22.23M |
| Total Liabilities | $34.17M | $46.42M | $56.84M | $69.24M | $68.84M | $43.69M | $34.10M | $36.21M |
| Total Debt (incl. Leases) | $2.03M | $2.30M | $2.39M | $2.42M | $2.62M | $2.15M | $2.24M | $2.51M |
| Common Stock | $537.4M | $535.7M | $529.7M | $515.5M | $494.2M | $490.6M | $489.3M | $484.7M |
| Retained Earnings | -$466.1M | -$470.3M | -$471.8M | -$467.0M | -$467.8M | -$438.1M | -$407.6M | -$403.5M |
| Accumulated Other Comp. Income | -$4.26M | -$4.47M | -$3.97M | -$3.92M | -$4.29M | -$4.10M | -$2.68M | -$2.88M |
| Total Stockholders' Equity | $67.06M | $60.92M | $53.88M | $44.55M | $22.04M | $48.38M | $79.03M | $78.38M |
| Total Equity | $65.94M | $59.80M | $52.70M | $43.35M | $20.80M | $47.11M | $77.66M | $77.01M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$63.37M | -$18.58M | -$21.48M | -$26.35M | -$43.27M | -$20.68M | -$11.83M | -$46.78M | -$23.29M | $18.62M |
| Depreciation & Amortization | $699K | $587K | $562K | $582K | $663K | $823K | $1.00M | $1.08M | $947K | $1.18M |
| Stock-Based Compensation | $4.75M | $5.08M | $4.64M | $4.29M | $3.52M | $2.23M | $3.58M | $5.40M | $3.93M | $7.95M |
| Change in Working Capital | -- | -- | -- | -- | -- | -- | -- | -$487K | -$22K | $56K |
| Change in Receivables | -$316K | $106K | -$446K | $50.31M | -$857K | $287K | $467K | $46K | -$172K | $187K |
| Change in Inventory | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| Operating Cash Flow | -$18.92M | -$23.09M | -$28.57M | $1.06M | -$23.56M | -$19.75M | -$31.95M | -$30.88M | -$30.52M | -$42.33M |
| Capital Expenditure | -$522K | -$565K | -$674K | -$413K | -$340K | -$64K | -$440K | -$556K | -$1.33M | -$2.25M |
| Free Cash Flow | -$19.44M | -$23.66M | -$29.24M | $646K | -$23.90M | -$19.82M | -$32.39M | -$31.44M | -$31.84M | -$44.57M |
| Purchases of Investments | -$14.94M | -$8.76M | -$16.40M | -$53.41M | -- | -- | -- | -- | -- | -- |
| Investing Cash Flow | -$13.46M | -$2.31M | $46.45M | -$46.16M | $9.74M | $13.04M | $16.96M | $11.82M | -$10.22M | -$10.89M |
| Common Stock Issued | -- | -- | $6.62M | $148K | $30.86M | $5.13M | $103K | -- | $48.88M | $20.12M |
| Financing Cash Flow | $26.95M | $35.86M | $6.42M | $1.63M | $36.93M | $29.86M | $617K | $5.77M | $55.39M | $32.78M |
| Net Change in Cash | -$5.03M | $10.36M | $24.06M | -$44.34M | $23.09M | $23.09M | -$14.30M | -$13.29M | $14.75M | -$20.14M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $4.23M | $1.54M | -$4.79M | $892K | -$29.75M | -$30.36M | -$4.14M | -$3.25M |
| Depreciation & Amortization | $202K | $187K | $188K | $186K | $178K | $171K | $164K | $151K |
| Stock-Based Compensation | $1.70M | $1.60M | $1.17M | $1.10M | $1.20M | $1.24M | $1.22M | $1.31M |
| Change in Receivables | -$544K | $19K | $154K | -$827K | $130K | -$43K | $424K | -$233K |
| Operating Cash Flow | -$5.62M | -$7.24M | -$8.08M | -$4.88M | -$3.62M | -$5.54M | -$4.89M | -$6.35M |
| Capital Expenditure | -$74K | -$108K | -$55K | -$399K | -$12K | -$14K | -$97K | -$365K |
| Free Cash Flow | -$5.69M | -$7.35M | -$8.13M | -$5.28M | -$3.63M | -$5.55M | -$4.98M | -$6.71M |
| Purchases of Investments | -$11.13M | -$10.43M | -$8.24M | -$14.94M | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$5.15M | $3.96M | -$2.33M | -$15.33M | -$12K | -$14K | $1.90M | $2.63M |
| Financing Cash Flow | -$23K | $4.47M | $5.56M | $20.38M | $1.83M | -$307K | $5.04M | $21.73M |
| Net Change in Cash | -$10.87M | $1.44M | -$4.85M | $347K | -$1.80M | -$5.57M | $1.99M | $18.05M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | 96.5% | 92.5% | 95.0% | 67.2% | 78.9% | 88.3% | 93.9% | 95.1% | 94.0% |
| Operating Margin | -251.6% | -226.1% | -276.5% | -153.2% | -1133.6% | -1448.4% | -1106.0% | -837.9% | -1125.0% | -995.6% |
| Net Profit Margin | -436.5% | -195.9% | -240.2% | -178.7% | -991.0% | -1130.8% | -333.1% | -922.0% | -577.7% | 566.8% |
| Return on Equity (ROE) | -142.6% | -23.7% | -33.9% | -35.8% | -46.6% | -21.5% | -10.4% | -49.9% | -12.3% | 28.5% |
| Return on Assets (ROA) | -56.4% | -16.4% | -21.3% | -21.2% | -24.6% | -19.1% | -9.3% | -45.2% | -11.5% | 23.5% |
| Current Ratio | 5.20x | 3.65x | 2.14x | 3.16x | 2.37x | 5.66x | 8.86x | 5.34x | 6.20x | 2.90x |
| Quick Ratio | 4.99x | 3.47x | 2.02x | 3.06x | 2.31x | 5.39x | 4.73x | 4.51x | 5.57x | 1.45x |
| Debt to Equity | 0.05x | 0.03x | 0.05x | 0.05x | 0.03x | 0.00x | 0.01x | 0.02x | -- | -- |
| Revenue Growth (YoY) | +53.2% | +6.2% | -39.2% | +238.7% | +137.7% | -48.1% | -29.5% | +44.2% | -41.6% | -15.8% |
| Gross Profit Growth (YoY) | -- | +10.8% | -40.8% | +379.4% | +102.3% | -53.6% | -33.8% | +42.4% | -40.9% | -6.1% |
| Net Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -159.5% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -- | -148.6% | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -2797.5% | -- | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -4626.3% | -- | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -99.5% | -99.8% | -99.9% | +186.7% | -56.6% | +13687.2% | +30513.1% | +47969.1% | -62.0% | -35.4% |
| 10Y Revenue / Share Growth | -28.3% | -39.9% | -36.6% | +8.8% | -72.0% | +13115.5% | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -175.8% | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | -- | -- | -- | 97.2% | 96.5% |
| Operating Margin | -280.3% | -205.2% | -255.1% | -251.6% | -325.3% | -322.8% | -223.1% | -226.1% |
| Net Profit Margin | 16.2% | -246.6% | -434.4% | -436.5% | -625.5% | -374.8% | -169.6% | -195.9% |
| Return on Equity (ROE) | 2.6% | -53.0% | -119.2% | -142.6% | -307.0% | -84.6% | -20.5% | -23.7% |
| Return on Assets (ROA) | 1.8% | -30.4% | -58.6% | -56.4% | -75.5% | -45.1% | -14.5% | -16.4% |
| Current Ratio | 5.96x | 6.61x | 6.89x | 5.20x | 4.50x | 4.08x | 3.82x | 3.65x |
| Quick Ratio | 5.80x | 6.44x | 6.65x | 4.99x | 4.33x | 3.96x | 3.68x | 3.47x |
| Debt to Equity | 0.03x | 0.04x | 0.04x | 0.05x | 0.12x | 0.04x | 0.03x | 0.03x |
| Revenue Growth (YoY) | -61.0% | -61.3% | +14.8% | +130.4% | -2.6% | +96.4% | +4.0% | +37.4% |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | +8.9% | +48.1% |